Exact Sciences Corp

NASDAQ: EXAS
$41.11
-$0.84 (-2.0%)
Real Time Data Delayed 15 Min.

EXAS Chart and Intraday Price

EXAS Company Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector TRADE & SERVICES
Industry SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Address 441 CHARMANY DRIVE, MADISON, WI, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 10,790.20M USD
Shares Outstanding 181,531,000
Exact Sciences Corp specializes in cancer screening and diagnostic tests, offering innovative solutions like Cologuard, a non-invasive test for colorectal cancer detection. Beyond colorectal health, it provides Oncotype DX tests for breast and colon cancer recurrence, and the OncoExTra Test for advanced cancers. The company is also involved in COVID-19 testing and is working on developing new blood and fluid-based tests for cancer detection. Founded in 1995 and based in Madison, Wisconsin, Exact Sciences continues to expand its diagnostic portfolio through partnerships with leading research institutions.

EXAS Articles

Analysts' first ratings changes for 2024 include some deletions from a top buy list and a downgrade for Apple.
Wednesday's top analyst upgrades and downgrades included Amazon.com, Arm, Corning, Dollar General, Electronic Arts, Estee Lauder, Juniper Networks, Next Era Energy Partners, Realty Income, Rivian...
Friday's top analyst upgrades and downgrades included Agilent, Boeing, General Electric, Lockheed Martin, Meta Platforms, Micron Technology, Redfin, Salesforce, Trade Desk, Unity Software and Workday.
For aggressive growth investors with plenty of risk tolerance, the time to buy these five top stocks from Cathie Wood's ARK Innovation ETF may be now, as they could see stellar growth in the coming...
For aggressive growth investors with ample risk tolerance and a long-term horizon, these five Cathie Woods ARK Innovation ETF holdings are almost guaranteed winners now and could provide some huge...
Thursday's top analyst upgrades and downgrades included Airbnb, Alcon, Antero Midstream, Exact Sciences, GitLab, GlobalFoundries, Halozyme Therapeutics, Lumentum, Nektar Therapeutics, PayPal and...
Monday's top analyst upgrades and downgrades included Apple, Atlassian, Block, CF Industries, Comerica, DraftKings, Exact Sciences, Global Payments, Kellogg, Mobileye Global, Shopify, VFC and Zions...
Friday's top analyst upgrades and downgrades included Advanced Micro Devices, Asana, Etsy, Exact Sciences, Guardant Health, Hilton Worldwide, Meta Platforms, MongoDB, Salesforce, ServiceNow, Sysco...
Friday's premarket trading session was picking up where Thursday's regular session ended.
Friday’s top analyst upgrades and downgrades included Danaher, Exact Sciences, First Majestic Silver, First Solar, Illumina, KB Home, NetApp, Nvidia, Salesforce, Snowflake, Splunk and TechnipFMC.
Thursday’s top analyst upgrades and downgrades included Advanced Micro Devices, Baxter International, Caesars Entertainment, Electronic Arts, Exact Sciences, Gilead Sciences, Intel, JetBlue...
Monday's top analyst upgrades and downgrades included Bristol-Myers Squibb, Cheniere Energy, Chewy, Costco Wholesale, CrowdStrike, Exact Sciences, Lululemon Athletica, New York Community Bancorp,...
Thursday's top analyst upgrades and downgrades included Alphabet, Allstate, Antero Midstream, Archer Daniels Midland, Capital One Financial, Chipotle Mexican Grill, Corning, Microsoft, PepsiCo,...
Wednesday's top analyst upgrades and downgrades included Airbnb, Amazon.com, Bank of America, Chipotle Mexican Grill, Comcast, Foot Locker, Kimberly-Clark, Meta Platforms, Novavax, Redfin, Synchrony...
Thursday's top analyst upgrades and downgrades included Caesars Entertainment, Chevron, Exact Sciences, Exxon Mobil, Gap, Ginkgo Bioworks, Home Depot, New York Mortgage Trust, Novavax, NOV and SoFi...